Collaborative cardiovascular risk reduction in primary care ii (CCARP II): Implementation of a systematic case-finding process for patients with uncontrolled risk factors

Canadian Pharmacists Journal

Volumn 146, Issue 5, 2013, Pages 284-292

  Yakiwchuk, Erin M ^a   Jorgenson, Derek ^a   Mansell, Kerry ^a   Laubscher, Tessa ^b   LeBras, Marlys ^a   Blackburn, David F ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; CARDIOVASCULAR RISK; CASE FINDING; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACEUTICAL CARE; PHARMACIST; PREVALENCE; PRIMARY HEALTH CARE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

EID: 84890192191     PISSN: 17151635     EISSN: 1913701X     Source Type: Journal    
DOI: 10.1177/1715163513499303     Document Type: Article

References (31)

1. Al Mazroui NR, Kamal MM, Ghabash NM, et al. Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus. Br J Clin Pharmacol 2009;67:547-57.
2. Anaya JP, Rivera JO, Lawson K, et al. Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health Syst Pharm 2008;65:1841-5.
3. Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a communitybased long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc (2003) 2008;48:23-31.
4. Carson JJ. Pharmacist-coordinated program to improve use of pharmacotherapies for reducing risk of coronary artery disease in low-income adults. Am J Health Syst Pharm 1999;56:2319-24.
5. Clifford RM, Davis WA, Batty KT, Davis TME. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2005;28:771-76.
6. Geber J. Optimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care setting. Pharmacotherapy 2002;22:738-47.
7. McCord AD. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy 2006;26:248-53.
8. Reid F, Murray P, Storrie M. Implementation of a pharmacist-led clinic for hypertensive patients in primary care-a pilot study. Pharm World Sci 2005;27:202-7.
9. Reilly V, Cavanagh M. The clinical and economic impact of a secondary heart disease prevention clinic jointly implemented by a practice nurse and pharmacist. Pharm World Sci 2003;25:294-8.
10. Simpson SH, Lewanczuk RZ, Majumdar SR, et al. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2011;34:20-6.
11. Taveira TH, Pirraglia PA, Cohen LB, Wu WC. Efficacy of a pharmacist-led cardiovascular risk reduction clinic for diabetic patients with and without mental health conditions. Prev Cardiol 2008;11:195-200.
12. Taveira TH, Wu WC, Martin OJ, et al. Pharmacist-led cardiac risk reduction model. Prev Cardiol 2006;9:202-8.
13. John EJ, Vavra T, Farris K, et al. Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight. Pharmacotherapy 2006;26:1511-7.
14. Lowey A, Moore S, Norris C, et al. The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes. Pharm World Sci 2007;29:541-5.
15. McGowan N, Cockburn A, Strachan MWJ, et al. Initial and sustained cardiovascular risk reduction in a pharmacistled diabetes cardiovascular risk clinic. Br J Diabetes Vasc Dis 2008;8:34-8.
16. Nkansah NT, Brewer JM, Connors R, Shermock KM. Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice. Am J Health Syst Pharm 2008;65:145-9.
17. Lee DS, Chiu M, Manuel DG, et al. Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic, and geographic risk factors. CMAJ 2009;181:E55-66.
18. Evans CD, Eurich DT, Taylor JG, Blackburn DF. The Collaborative Cardiovascular Risk Reduction in Primary Care (CCARP) study. Pharmacotherapy 2010;30:766-75.
19. Rothman RL, Malone R, Bryant B, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005;118:276-84.
20. Kassamali A, Houle S, Rosenthal M, Tsuyuki RT. Case finding: the missing link in chronic disease management. Can Pharm J (Ott) 2011;144:170-2.
21. Genest J, McPherson R, Frolich J, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. Can J Cardiol 2009;25:567-79.
22. Khan NA, Hemmelgarn B, Herman RJ, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol 2009;25:287-98.
23. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32:S1-S201.
24. Saskatchewan College of Pharmacists. Regulatory bylaw amendments pursuant to the Pharmacy Act 1996. Available: http://scp.in1touch.org/uploaded/58/web/site/Prescribing_Bylaws_Apprvd_Council_20101224.pdf (accessed July 4, 2013).
25. Jebb SA, Ahern AL, Olson AD, et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomized controlled trial. Lancet 2011;378:1485-92.
26. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009;169:1996-2002.
27. Hutchison BG, Abelson J, Woodward CA, Norman G. Preventive care and barriers to effective prevention: how do family physicians see it? Can Fam Phys 1996;42:1693-700.
28. Primary Health Services Branch SH. The Saskatchewan Action Plan for Primary Health Care. 2002. Available: www.slideshare.net/primary/the-sk-action-plan-for-primaryhealth-care (accessed July 2, 2013).
29. Government of Alberta. Compensation for pharmacy services. Available: www.health.alberta.ca/documents/Pharmacy-Services-Compensation-2012.pdf (accessed Jan. 28, 2013).
30. Capewell S, O'Flaherty M. Trends in cardiovascular disease: are we winning the war? CMAJ 2009;180:1285-6.
31. Leenen FHH, Dumais J, McInnis NH, et al. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008;178:1441-9.